Footprint-free human induced pluripotent stem cells from articular cartilage with redifferentiation capacity: A first step toward a clinical-grade cell source

Stem Cells Translational Medicine

Volumn 3, Issue 4, 2014, Pages 433-447

  BorestrÖm, Cecilia ^a   Simonsson, Stina ^a   Enochson, Lars ^a   Bigdeli, Narmin ^a   Brantsing, Camilla ^a   EllerstrÖm, Catharina ^b   Hyllner, Johan ^c,d   Lindahl, Anders ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Arvid Wallgrens Backe 20   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

^d CELL AND GENE THERAPY CATAPULT   (United Kingdom)

Author keywords

Chondrocytes; Chondrogenesis; Induced pluripotency; Induced pluripotent stem cells; mRNA; Reprogramming

Indexed keywords

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CHONDROCYTE IMPLANTATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; FIBROBLAST; GENE EXPRESSION; GENOMIC INSTABILITY; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KARYOTYPING; MESENCHYMAL STEM CELL; OSTEOARTHRITIS; PLURIPOTENT STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN BLOTTING;

CHONDROCYTES; CHONDROGENESIS; INDUCED PLURIPOTENCY; INDUCED PLURIPOTENT STEM CELLS; MRNA; REPROGRAMMING;

CARTILAGE; CELL DEDIFFERENTIATION; CELLS, CULTURED; CHONDROCYTES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MESENCHYMAL STROMAL CELLS;

EID: 84897557412     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0138     Document Type: Article

References (49)

1. Brittberg M, Lindahl A, Nilsson A et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994;331:889-895.
2. Vasiliadis HS, Danielson B, Ljungberg M et al. Autologous chondrocyte implantation in cartilage lesions of the knee: Long-term evaluation with magnetic resonance imaging and delayed gadolinium-enhanced magnetic resonance imaging technique. Am J Sports Med 2010;38:943-949.
3. Peterson L, Vasiliadis HS, Brittberg M et al. Autologous chondrocyte implantation: A longterm follow-up. Am J Sports Med 2010;38: 1117-1124.
4. Tallheden T, Dennis JE, Lennon DP et al. Phenotypic plasticity of human articular chondrocytes. J Bone Joint Surg Am 2003;85-A(Suppl 2):93-100.
5. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
6. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
7. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872.
8. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318: 1917-1920.
9. Maherali N, Ahfeldt T, Rigamonti A et al. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 2008;3:340-345.
10. Kim K, Zhao R, Doi A et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol 2011;29:1117-1119.
11. Kim K, Doi A, Wen B et al. Epigenetic memory in induced pluripotent stem cells. Nature 2010;467:285-290.
12. Polo JM, Liu S, Figueroa ME et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 2010;28: 848-855.
13. Okita K, Nakagawa M, Hyenjong H et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008;322: 949-953.
14. Gonzalez F, Barragan Monasterio M, Tiscornia G et al. Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc Natl Acad Sci USA 2009;106:8918-8922.
15. Stadtfeld M, Nagaya M, Utikal J et al. Induced pluripotent stem cells generated without viral integration. Science 2008;322: 945-949.
16. Yu J, Hu K, Smuga-Otto K et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009;324: 797-801.
17. Jia F, Wilson KD, Sun N et al. A nonviral minicircle vector for deriving human iPS cells. Nat Methods 2010;7:197-199.
18. Soldner F, Hockemeyer D, Beard C et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009;136:964-977.
19. Chang CW, Lai YS, Pawlik KM et al. Polycistronic lentiviral vector for "hit and run" reprogramming of adult skin fibroblasts to induced pluripotent stem cells. STEM CELLS 2009; 27:1042-1049.
20. Yusa K, Rad R, Takeda J et al. Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods 2009;6:363-369.
21. Woltjen K, Michael IP, Mohseni P et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009;458:766-770.
22. Warren L, Manos PD, Ahfeldt T et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010; 7:618-630.
23. Okita K, Matsumura Y, Sato Y et al. A more efficient method to generate integration-free human iPS cells. Nat Methods 2011;8:409-412.
24. Oldershaw RA, Baxter MA, Lowe ET et al. Directed differentiation of human embryonic stem cells toward chondrocytes. Nat Biotechnol 2010;28:1187-1194.
25. Koyama N, Miura M, Nakao K et al. Human induced pluripotent stem cells differentiated into chondrogenic lineage via generation of mesenchymal progenitor cells. Stem Cells Dev 2013;22:102-113.
26. Tallheden T, van der Lee J, Brantsing C et al. Human serum for culture of articular chondrocytes. Cell Transplant 2005;14:469-479.
27. Bigdeli N, Andersson M, Strehl R et al. Adaptation of human embryonic stem cells to feeder-free and matrix-free culture conditions directly on plastic surfaces. J Biotechnol 2008; 133:146-153.
28. Stenberg J, Elovsson M, Strehl R et al. Sustained embryoid body formation and culture in a non-laborious three dimensional culture system for human embryonic stem cells. Cytotechnology 2011;63:227-237.
29. Synnergren J, Giesler TL, Adak S et al. Differentiating human embryonic stem cells transitions of pluripotency entry and differentiation into all embryonic lineages. Nat Cell Biol 2013;15:579-590.
30. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408.
31. DeLise AM, Fischer L, Tuan RS. Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage 2000;8:309-334.
32. Goldring MB, Tsuchimochi K, Ijiri K. The control of chondrogenesis. J Cell Biochem 2006;97:33-44.
33. Taapken SM, Nisler BS, NewtonMAet al. Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells. Nat Biotechnol 2011;29:313-314.
34. Lister R, Pelizzola M, Kida YS et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 2011;471:68-73.
35. Hussein SM, Batada NN, Vuoristo S et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011; 471:58-62.
36. Martins-Taylor K, Nisler BS, Taapken SM et al. Recurrent copy number variations in human induced pluripotent stem cells. Nat Biotechnol 2011;29:488-491.
37. Mayshar Y, Ben-David U, Lavon N et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010;7:521-531.
38. Chin MH, Mason MJ, XieWet al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009;5:111-123.
39. ElliottAM, Elliott KA, Kammesheidt A. High resolution array-CGH characterization of human stem cells using a stem cell focused microarray. Mol Biotechnol 2010;46:234-242.
40. Laurent LC, Ulitsky I, Slavin I et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 2011;8:106-118.
41. Ji J, Ng SH, Sharma V et al. Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells. STEM CELLS 2012;30:435-440.
42. Ryan MC, Sandell LJ. Differential expression of a cysteine-rich domain in the aminoterminal propeptide of type II (cartilage) procollagen by alternative splicing of mRNA. J Biol Chem 1990;265:10334-10339.
43. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000;24:372-376.
44. Radzisheuskaya A, Chia GB, dos Santos RL et al. A defined Oct4 level governs cell state 446 Footprint-Free Chondrocyte-Derived Human iPSCs transitions of pluripotency entry and differentiation into all embryonic lineages. Nat Cell Biol 2013;15:579-590.
45. Papapetrou EP, Tomishima MJ, Chambers SM et al. Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc Natl Acad Sci USA 2009; 106:12759-12764.
46. Pelttari K, Winter A, Steck E et al. Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum 2006;54:3254-3266.
47. Miura K, Okada Y, Aoi T et al. Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol 2009;27:743-745.
48. Hu BY, Weick JP, Yu J et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 2010; 107:4335-4340.
49. Simonsson S, Gurdon J. DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei. Nat Cell Biol 2004;6: 984-990.